Download MendeleyDynamics and structural changes of calmodulin upon interaction with the antagonist calmidazolium.
Leger, C., Pitard, I., Sadi, M., Carvalho, N., Brier, S., Mechaly, A., Raoux-Barbot, D., Davi, M., Hoos, S., Weber, P., Vachette, P., Durand, D., Haouz, A., Guijarro, J.I., Ladant, D., Chenal, A.(2022) BMC Biol 20: 176-176
- PubMed: 35945584
- DOI: https://doi.org/10.1186/s12915-022-01381-5
- Primary Citation of Related Structures:
7PSZ, 7PU9 - PubMed Abstract:
Calmodulin (CaM) is an evolutionarily conserved eukaryotic multifunctional protein that functions as the major sensor of intracellular calcium signaling. Its calcium-modulated function regulates the activity of numerous effector proteins involved in a variety of physiological processes in diverse organs, from proliferation and apoptosis, to memory and immune responses. Due to the pleiotropic roles of CaM in normal and pathological cell functions, CaM antagonists are needed for fundamental studies as well as for potential therapeutic applications. Calmidazolium (CDZ) is a potent small molecule antagonist of CaM and one the most widely used inhibitors of CaM in cell biology. Yet, CDZ, as all other CaM antagonists described thus far, also affects additional cellular targets and its lack of selectivity hinders its application for dissecting calcium/CaM signaling. A better understanding of CaM:CDZ interaction is key to design analogs with improved selectivity. Here, we report a molecular characterization of CaM:CDZ complexes using an integrative structural biology approach combining SEC-SAXS, X-ray crystallography, HDX-MS, and NMR.
Organizational Affiliation:
Biochemistry of Macromolecular Interactions Unit, Department of Structural Biology and Chemistry, CNRS UMR3528, Institut Pasteur, Paris, 75015, France.
